These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
924 related articles for article (PubMed ID: 17876837)
1. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837 [TBL] [Abstract][Full Text] [Related]
2. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197 [TBL] [Abstract][Full Text] [Related]
3. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment. Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238 [TBL] [Abstract][Full Text] [Related]
4. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer. Tomizawa Y; Iijima H; Nomoto T; Iwasaki Y; Otani Y; Tsuchiya S; Saito R; Dobashi K; Nakajima T; Mori M Lung Cancer; 2004 Dec; 46(3):305-12. PubMed ID: 15541815 [TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099 [TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
11. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724 [TBL] [Abstract][Full Text] [Related]
12. DNA methylation markers and early recurrence in stage I lung cancer. Brock MV; Hooker CM; Ota-Machida E; Han Y; Guo M; Ames S; Glöckner S; Piantadosi S; Gabrielson E; Pridham G; Pelosky K; Belinsky SA; Yang SC; Baylin SB; Herman JG N Engl J Med; 2008 Mar; 358(11):1118-28. PubMed ID: 18337602 [TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584 [TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
15. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913 [TBL] [Abstract][Full Text] [Related]
16. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
17. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703 [TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794 [TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood. Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]